CHINA PHARMA HOLDINGS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
China Pharma Holdings, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • China Pharma Holdings, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 12, 2024 was 19.3M shares, a 41.6% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 19.3M -13.7M -41.6% Nov 12, 2024 10-Q 2024-11-13
Q2 2024 17.2M +5.73M +50.1% Aug 12, 2024 10-Q 2024-08-14
Q1 2024 14.8M +6.36M +75.2% Mar 24, 2024 10-K 2024-04-01
Q3 2023 33M -18.7M -36.2% Nov 10, 2023 10-Q 2023-11-13
Q2 2023 11.4M -39M -77.3% Aug 7, 2023 10-Q 2023-08-14
Q1 2023 8.46M -38.9M -82.1% Mar 24, 2023 10-K 2023-03-30
Q3 2022 51.6M +4.3M +9.09% Nov 9, 2022 10-Q 2022-11-14
Q2 2022 50.4M +6.87M +15.8% Aug 10, 2022 10-Q 2022-08-11
Q1 2022 47.3M +1.76M +3.86% Mar 22, 2022 10-K 2022-03-30
Q3 2021 47.3M +3.76M +8.63% Nov 10, 2021 10-Q 2021-11-12
Q2 2021 43.6M 0 0% Aug 5, 2021 10-Q 2021-08-13
Q1 2021 45.6M +2M +4.59% Mar 22, 2021 10-K 2021-03-26
Q3 2020 43.6M 0 0% Nov 12, 2020 10-Q 2020-11-13
Q2 2020 43.6M 0 0% Aug 13, 2020 10-Q 2020-08-13
Q1 2020 43.6M 0 0% Mar 20, 2020 10-K 2020-03-30
Q3 2019 43.6M 0 0% Nov 8, 2019 10-Q 2019-11-14
Q2 2019 43.6M 0 0% Aug 12, 2019 10-Q 2019-08-14
Q1 2019 43.6M 0 0% Mar 26, 2019 10-K 2019-03-28
Q3 2018 43.6M 0 0% Nov 9, 2018 10-Q 2018-11-14
Q2 2018 43.6M 0 0% Aug 9, 2018 10-Q 2018-08-14
Q1 2018 43.6M 0 0% Mar 27, 2018 10-K 2018-04-02
Q3 2017 43.6M 0 0% Nov 10, 2017 10-Q 2017-11-14
Q2 2017 43.6M 0 0% Aug 10, 2017 10-Q 2017-08-14
Q1 2017 43.6M 0 0% Mar 29, 2017 10-K 2017-03-31
Q3 2016 43.6M 0 0% Nov 8, 2016 10-Q 2016-11-14
Q2 2016 43.6M 0 0% Aug 8, 2016 10-Q 2016-08-11
Q1 2016 43.6M 0 0% Mar 28, 2016 10-K 2016-03-30
Q4 2015 43.6M Nov 20, 2015 10-Q 2015-11-16
Q3 2015 43.6M 0 0% Nov 11, 2015 10-Q/A 2015-12-28
Q2 2015 43.6M 0 0% Aug 11, 2015 10-Q/A 2015-12-28
Q1 2015 43.6M 0 0% Mar 19, 2015 10-K/A 2015-12-28
Q3 2014 43.6M 0 0% Nov 10, 2014 10-Q 2014-11-14
Q2 2014 43.6M 0 0% Aug 11, 2014 10-Q 2014-08-14
Q1 2014 43.6M 0 0% May 12, 2014 10-Q 2014-05-15
Q4 2013 43.6M Dec 31, 2013 10-K 2014-03-20
Q3 2013 43.6M 0 0% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 43.6M +50K +0.12% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 43.6M +50K +0.12% Mar 14, 2013 10-K 2013-03-14
Q3 2012 43.6M +50K +0.12% Nov 9, 2012 10-Q 2012-11-14
Q2 2012 43.5M 0 0% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 43.5M Mar 31, 2012 10-Q 2012-05-14
Q3 2011 43.5M Sep 30, 2011 10-Q/A 2012-03-06
Q2 2011 43.5M Aug 9, 2011 10-Q/A 2011-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.